EMD – Emyria Ltd


Subscribe for full access

Unlock Industry-grade Shariah Compliance for US, UK, Canada, Germany, GCC, Europe and India. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.

Get started from just $1/month


1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Total Analysts: 0

Company Profile

Emyria Limited is an Australia-based company, which develops biopharmaceuticals guided by real-world data collected with patients across its clinical service subsidiary, Emerald Clinics. The Company is staffed and managed by medical practitioners, including Specialists and General Practitioners. The Company operates seven clinical sites around Australia. Patient appointments can be made in clinic or via Telehealth once a referral is received. It has seen approximately 5000 patients with over 40 clinical indications for patients between the ages of 2-96 years. The Company’s clinician-led care teams provide personalized, evidence-generating care for patients with unmet needs. The Company monitors and evaluates new treatments while generating insights that help it provide individualized care. It treats approximately 44 different debilitating and health concerns, including mental health, chronic pain, addiction, neurodegenerative, gastrointestinal and musculoskeletal conditions.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan